Abstract
Background Iron has been proposed as a risk factor for atherosclerosis but the data are controversial. We previously showed that non-transferrin-bound iron (a fraction of iron appearing in iron overload) contributes to atherosclerosis. Here, we investigated whether iron within physiological limits influenced atherosclerosis by studying its association with vascular dysfunction and peripheral arterial disease (PAD). Further, we evaluated if this relationship was influenced by comorbidities.
Methods We studied the association between iron biomarkers in blood and markers for vascular adhesion and PAD in 368 individuals registered in the Heidelberg Study on Diabetes and Complications (HEIST-DiC). Our observations were validated by analyzing the association between iron biomarkers and PAD in the National Health and Nutrition Examination Survey (NHANES 1999-2004) data.
Results In both HEIST-DiC and NHANES cohorts, plasma ferritin levels are positively associated with PAD in females and not in males. We further identified negative associations between TIBC and plasma iron levels with PAD among females. These relationships were independent of the presence of other comorbidities including hypertension, insulin resistance, prediabetes, and diabetes.
Conclusion We demonstrate a sex-specific alteration of markers of systemic iron availability in individuals with clinically apparent PAD implying that mechanisms of disease development may differ between males and females. Elevated ferritin levels and hypoferremia in females are indicative of an underlying inflammation that may affect the pathogenesis of PAD. The observed lack of a positive association of PAD with serum iron levels suggest that “physiological” iron concentrations are safe for vascular health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The HEIST-DiC study was funded by the Deutsche Forschungsgemeinschaft (SFB1118). MUM received funding from the DFG (SFB1118) and Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL; Project No. FKZ 82DZL004A1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committees of the University of Heidelberg approved this study (Decision No. 204/2004, 400/2010 and S-383/2016) according to the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data from this study can be explored here: https://anandr.shinyapps.io/NHANES-HEISTDiC/. The HEIST-DiC dataset analyzed in the current study is available from the corresponding authors on reasonable request. The NHANES dataset is publicly available. Codes used for data analysis and visualization are accessible here (https://github.com/griffindoc/pad)
